TWO · —

Orient EuroPharma Co., Ltd. (4120.TWO) Stock

$45.80 -0.43% TWO: 4120.TWO —

—

Valuation

Metric	Value
Price	$45.80
Market Cap	$3.99B
P/E Ratio	—
P/B Ratio	0.76
P/S Ratio	0.86
EPS (TTM)	$-6.64
52-Week High	$50.00
52-Week Low	$42.60
Dividend Yield	8.71%

Financials & Margins

Metric	Value
ROE	-7.15%
ROA	-1.82%
ROCE	—
Gross Margin	48.77%
Operating Margin	-10.54%
Net Margin	-12.38%
Debt/Equity	0.56
Current Ratio	1.16

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	—
Quick Ratio	—
Interest Coverage	—
Return 1Y	1.14%
Return 3Y	28.79%
Return 5Y	35.10%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
1720.TWStandard Chemical & Pharmaceutical Co., Ltd.	$56.80	-1.90%	11.57	$11.32B	3.45%
1734.TWSinphar Pharmaceutical Co.,Ltd.	$31.25	-1.57%	18.96	$6.65B	3.03%
3054.TWLIWANLI Innovation Co., Ltd.	$55.00	-1.96%	—	—	0.00%
4105.TWOTTY Biopharm Company Limited	$80.60	-0.74%	11.58	$20.04B	5.54%
4108.TWPhytoHealth Corporation	$11.20	+0.00%	—	$2.29B	0.00%

About Orient EuroPharma Co., Ltd.

—

Orient EuroPharma Co., Ltd. is led by CEO Mon-Lin Tsai, employs 339 people, headquartered in Taipei, TW, publicly traded since 2007.

Orient EuroPharma Co., Ltd. (4120.TWO) stock trades at $45.80 with a market capitalization of $3.99B. The stock is valued at price-to-book of 0.76, price-to-sales of 0.86. Over the past 52 weeks the stock has ranged between $42.60 and $50.00, and currently trades 8.4% below its 52-week high. It pays a dividend yielding 8.71%.

On profitability, Orient EuroPharma Co., Ltd. generates a return on equity (ROE) of -7.15% (negative, reflecting a net loss), an operating margin of -10.54%, a net profit margin of -12.38%.

Official website: www.oepgroup.com

Orient EuroPharma Co., Ltd. (4120.TWO) — frequently asked questions

What is Orient EuroPharma Co., Ltd. (4120.TWO) stock price today?

Orient EuroPharma Co., Ltd. (4120.TWO) is currently trading at $45.80, down 0.43% today.

What is 4120.TWO return on equity (ROE)?

Orient EuroPharma Co., Ltd.'s return on equity (ROE) is -7.15%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is Orient EuroPharma Co., Ltd.'s market cap?

Orient EuroPharma Co., Ltd. has a market capitalization of $3.99B.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% ALMR Alamar Biosciences, Inc. $28.74 -8.62% AVLN Avalyn Pharma Inc. $27.13 +8.03%

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.